Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEADERS Free Japan
NCT02348021Phase 3Unknown
- Sponsor
- Biosensors International Group, Ltd.
- Start
- Jul 2014
- Primary completion
- Apr 2016
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial in coronary artery disease (CAD), sponsored by Biosensors International Group, Ltd. Primary endpoints: Composite of cardiac death, myocardial infarction, and definite/probable stent thrombosis at 1 year and Clinically Driven Target Lesion Revascularization at 1 year. Status: unknown.
02
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02348021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02348021.